- Home
- DNTH vs MQY Comparison
DNTH vs MQY Comparison
Compare DNTH & MQY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- MQY
- Stock Information
- Founded
- DNTH 2015
- MQY 1994
- Country
- DNTH United States
- MQY United States
- Employees
- DNTH N/A
- MQY N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- MQY Investment Bankers/Brokers/Service
- Sector
- DNTH Health Care
- MQY Finance
- Exchange
- DNTH Nasdaq
- MQY Nasdaq
- Market Cap
- DNTH 724.8M
- MQY 836.9M
- IPO Year
- DNTH N/A
- MQY N/A
- Fundamental
- Price
- DNTH $18.14
- MQY $11.75
- Analyst Decision
- DNTH Strong Buy
- MQY
- Analyst Count
- DNTH 8
- MQY 0
- Target Price
- DNTH $54.33
- MQY N/A
- AVG Volume (30 Days)
- DNTH 362.0K
- MQY 184.8K
- Earning Date
- DNTH 03-11-2025
- MQY 01-01-0001
- Dividend Yield
- DNTH N/A
- MQY 4.73%
- EPS Growth
- DNTH N/A
- MQY N/A
- EPS
- DNTH N/A
- MQY N/A
- Revenue
- DNTH $6,235,000.00
- MQY N/A
- Revenue This Year
- DNTH N/A
- MQY N/A
- Revenue Next Year
- DNTH N/A
- MQY N/A
- P/E Ratio
- DNTH N/A
- MQY N/A
- Revenue Growth
- DNTH 120.63
- MQY N/A
- 52 Week Low
- DNTH $17.50
- MQY $9.82
- 52 Week High
- DNTH $32.27
- MQY $12.52
- Technical
- Relative Strength Index (RSI)
- DNTH 36.91
- MQY 46.06
- Support Level
- DNTH $17.50
- MQY $11.63
- Resistance Level
- DNTH $20.45
- MQY $11.82
- Average True Range (ATR)
- DNTH 1.67
- MQY 0.13
- MACD
- DNTH -0.22
- MQY 0.00
- Stochastic Oscillator
- DNTH 10.44
- MQY 53.19
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About MQY Blackrock MuniYield Quality Fund Inc.
Blackrock Muniyield Quality Fund Inc is a closed-end management investment company. The company's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.